{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:43:19Z","timestamp":1746171799188},"reference-count":52,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Canada Research Chair in Pharmaco-epidemiology and Vaccine Evaluation and the Great-West Life, London Life and Canada Life Junior Investigator of the Canadian Cancer Society","award":["2011-700644"],"award-info":[{"award-number":["2011-700644"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epidemiological study findings regarding the association between use of non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) and risk of non\u2010Hodgkin lymphoma (NHL) have been inconsistent. We aimed to systematically review epidemiological studies of the association and calculate pooled relative risks using meta\u2010analytic methods. We searched eight electronic literature databases and three clinical trial registers to identify all studies (including observational studies and randomized clinical trials) of the association published prior to October 2013. Identified studies were independently reviewed by two researchers. We used a random effects model to calculate pooled odds ratio (PORs). Heterogeneity amongst studies was examined using Cochran's Q and I\u2010squared (I<jats:sup>2<\/jats:sup>) tests; and sources of heterogeneity were explored using subgroup and meta\u2010regression analyses. A total of 17 studies (12 case\u2010control studies and five cohort studies), all adult studies, were included. Use of NSAIDs was not associated with overall risk of NHL [POR\u2009=\u20091.05, and 95% confidence interval (95% CI) 0.90\u20131.22] or NHL subtypes including B\u2010cell lymphoma, T\u2010cell lymphoma, follicular lymphoma, diffuse large B\u2010cell lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL). Aspirin use was associated with reduced risk of CLL\/SLL (POR\u2009=\u20090.70, 95% CI 0.54\u20130.91) but not with the risk of all NHLs (POR\u2009=\u20091.02, 95% CI 0.89\u20131.17). Use of non\u2010aspirin NSAIDs was associated with increased risk of NHL (POR\u2009=\u20091.41, 95% CI 1.01\u20131.97) amongst females only. The epidemiologic evidence remains inconclusive. Effects of NSAIDs may differ by drug type, NHL subtype, and sex and more studies taking into consideration these differences are needed. Copyright \u00a9 2014 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.2165","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T21:46:13Z","timestamp":1414100773000},"page":"176-186","source":"Crossref","is-referenced-by-count":6,"title":["Use of non\u2010steroidal anti\u2010inflammatory drugs and risk of non\u2010Hodgkin lymphoma: a systematic review and meta\u2010analysis"],"prefix":"10.1002","volume":"33","author":[{"given":"Xibiao","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Community Health Sciences, Faculty of Medicine University of Manitoba  Winnipeg Manitoba Canada"},{"name":"Centre for Healthcare Innovation Winnipeg Regional Health Authority\/University of Manitoba  Winnipeg Manitoba Canada"},{"name":"Vaccine and Drug Evaluation Centre University of Manitoba  Winnipeg Manitoba Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Casaclang","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Faculty of Medicine University of Manitoba  Winnipeg Manitoba Canada"},{"name":"Vaccine and Drug Evaluation Centre University of Manitoba  Winnipeg Manitoba Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salaheddin M.","family":"Mahmud","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Faculty of Medicine University of Manitoba  Winnipeg Manitoba Canada"},{"name":"Centre for Healthcare Innovation Winnipeg Regional Health Authority\/University of Manitoba  Winnipeg Manitoba Canada"},{"name":"Vaccine and Drug Evaluation Centre University of Manitoba  Winnipeg Manitoba Canada"},{"name":"Population and Public Health Program Winnipeg Regional Health Authority  Winnipeg Manitoba Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,23]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"Cancer Incidence in Five Continents","author":"Forman D","year":"2013"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2011.09.010"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25186"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00010"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1801"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802108854"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11311"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji293"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-1158"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021953224822"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2005.12.002"},{"issue":"19","key":"e_1_2_8_14_1","first-page":"5510s","article-title":"Prior medication use and health history as risk factors for non\u2010Hodgkin's lymphoma: preliminary results from a case\u2010control study in Los Angeles County","volume":"52","author":"Bernstein L","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008751"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg004"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj223"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.6346"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:CACO.0000027506.55846.5d"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010017"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg145"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-004-3074-9"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel396"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-007-9082-9"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24456"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/009286150403800104"},{"key":"e_1_2_8_28_1","first-page":"1","article-title":"Systems to rate the strength of scientific evidence","volume":"47","author":"West S","year":"2002","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.11.1054"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X0800800403"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199403000-00003"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.252"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.47"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk132"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj004"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199603000-00005"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0250"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.012"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127578.21885.3E"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/978930"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1517\/17530059.2011.618185"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2404"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25730"},{"key":"e_1_2_8_48_1","first-page":"757","volume-title":"Pharmacoepidemiology","author":"West SL","year":"2011"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117563"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.199"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.4.252"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015788502099"},{"key":"e_1_2_8_53_1","volume-title":"Non\u2010steroidal Anti\u2010inflammatory Drugs","year":"1997"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2165","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:35:11Z","timestamp":1696394111000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,23]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1002\/hon.2165"],"URL":"https:\/\/doi.org\/10.1002\/hon.2165","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,23]]}}}